|Goldman Sachs||Salveen Richter, CFA|
|Guggenheim Securities||Yatin Suneja|
|SVB Leerink||Marc Goodman|
|Oppenheimer & Co.||Jay Olson, CFA|
|Truist Securities||Joon Lee, M.D., Ph.D.|
Relmada Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Relmada Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Relmada Therapeutics, Inc. or its management. Relmada Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.